PuSH - Publication Server of Helmholtz Zentrum München

The impact of TGF-β on lung fibrosis: From targeting to biomarkers.

Ann. Am. Thorac. Soc. 9, 111-116 (2012)
Publ. Version/Full Text Volltext DOI PMC
Closed
Open Access Green as soon as Postprint is submitted to ZB.
Transforming growth factor-β (TGF-β) is extensively involved in the development of fibrosis in different organs. Overproduction or potentiation of its profibrotic effects leads to an aberrant wound healing response during the initiation of fibrotic processes. Idiopathic pulmonary fibrosis (IPF) is a chronic, devastating disease, in which TGF-βx{2013}induced disturbances of the homeostatic microenvironment are critical to promote cell activation, migration, invasion, or hyperplastic changes. In addition, excess extracellular matrix production contributes in a major way to disease pathogenesis. For this reason, this review will focus on discussing novel data and highlight growing interest in deepening the understanding of the profibrotic role of TGF-β and its direct or indirect targeting for disease modulation.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
0.000
1.663
440
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Review
Language english
Publication Year 2012
HGF-reported in Year 0
ISSN (print) / ISBN 2329-6933
e-ISSN 2325-6621
Quellenangaben Volume: 9, Issue: 3, Pages: 111-116 Article Number: , Supplement: ,
Publisher American Thoracic Society
Publishing Place New York, NY
Reviewing status Peer reviewed
POF-Topic(s) 30202 - Environmental Health
Research field(s) Lung Research
PSP Element(s) G-501600-001
PubMed ID 22802283
Erfassungsdatum 2012-07-23